title: Specific mutations in transmembrane helix 8 of human concentrative Na+/nucleoside cotransporter hCNT1 affect permeant selectivity and cation coupling.
abstract: The Na+/nucleoside cotransporters hCNT1 (650 residues) and hCNT2 (658 residues) are 72% identical in amino acid sequence and contain 13 putative transmembrane helices (TMs). Both transport uridine and adenosine but are otherwise selective for pyrimidine (system cit) and purine (system cif) nucleosides, respectively. Previously, we used site-directed mutagenesis and functional expression in Xenopus oocytes to identify two pairs of adjacent residues in TMs 7 and 8 of hCNT1 (Ser319-Gln320 and Ser353-Leu354) that, when converted to the corresponding residues in hCNT2 (Gly-Met and Thr-Val, respectively), changed the permeant selectivity of the transporter from cit to cif. We now report an investigation of the effects of corresponding mutations in TM 8 alone and demonstrate unique S353T- and L354V-induced changes in nucleoside specificity and cation coupling, respectively. hCNT1 mutation S353T produced a profound decrease in cytidine transport efficiency (Vmax/Km ratio) and, in combination with L354V (S353T/L354V), resulted in a novel uridine-preferring transport phenotype. In addition, the L354V mutation markedly increased the apparent affinity of hCNT1 for Na+ and Li+. Both hCNT1 TM 8 residues exhibited uridine-protectable inhibition by p-chloromercuribenzene sulfonate when converted to Cys, suggesting that they occupy positions within or closely adjacent to a common cation/nucleoside translocation pore.
authors.affiliation: Membrane Protein Research Group, Department of Physiology, University of Alberta, Edmonton, Canada.
authors.forename: Melissa D
authors.initials: MD
authors.lastname: Slugoski
authors.forename: Shaun K
authors.initials: SK
authors.lastname: Loewen
authors.forename: Amy M L
authors.initials: AM
authors.lastname: Ng
authors.forename: Kyla M
authors.initials: KM
authors.lastname: Smith
authors.forename: Sylvia Y M
authors.initials: SY
authors.lastname: Yao
authors.forename: Edward
authors.initials: E
authors.lastname: Karpinski
authors.forename: Carol E
authors.initials: CE
authors.lastname: Cass
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Baldwin
authors.forename: James D
authors.initials: JD
authors.lastname: Young
mesh_terms: D002731:4-Chloromercuribenzenesulfonate / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D002414:Cations, Monovalent / Q000378:metabolism; D003562:Cytidine / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D007930:Leucine / Q000502:physiology; D008094:Lithium / Q000378:metabolism; D026901:Membrane Transport Proteins / Q000737:chemistry / Q000235:genetics* / Q000502:physiology*; D017433:Protein Structure, Secondary; D012694:Serine / Q000502:physiology; D012964:Sodium / Q000378:metabolism; D013379:Substrate Specificity; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism; D014982:Xenopus laevis
chemical_list: D002414:Cations, Monovalent; D026901:Membrane Transport Proteins; C065171:cif nucleoside transporter; D012694:Serine; D003562:Cytidine; D002731:4-Chloromercuribenzenesulfonate; D008094:Lithium; D012964:Sodium; D007930:Leucine; D013936:Thymidine; D014529:Uridine